from Reuters: Business News http://ift.tt/2EkCoQu
Monday, 29 January 2018
How Sanofi's setback could lead to better dengue vaccines
CHICAGO (Reuters) - New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi's Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year.
from Reuters: Business News http://ift.tt/2EkCoQu
from Reuters: Business News http://ift.tt/2EkCoQu
Subscribe to:
Post Comments (Atom)
OpenAI's recently departed VP of research calls Google's comeback 'OpenAI's fumble'
OpenAI CEO Sam Altman Justin Sullivan/Getty Images Jerry Tworek, former VP of research at OpenAI , said the startup fumbled its lead ov...
-
Caroline Purser/Getty Images The S&P 500 has shed 4% since the beginning of the year as Big Tech stocks decline. However, previou...
-
AP Photo The Magnificent Seven stocks' dominance may soon fade, warns Glenmede Investment Management. Current market concentratio...
-
The Bell V-280 Valor was selected as the Army's future long-range assault aircraft in 2022. Photo courtesy of Bell The US Army desi...
No comments:
Post a Comment